LB Pharmaceuticals Inc
LBRX
$47.78
$3.517.92%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -51.60M | -19.05M | -11.47M | -3.56M | -5.09M |
| Total Depreciation and Amortization | 97.00K | 82.00K | 85.00K | 81.00K | 77.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.59M | 2.43M | 2.81M | 199.00K | 157.00K |
| Change in Net Operating Assets | 8.29M | -6.75M | -9.53M | -97.00K | -2.01M |
| Cash from Operations | -37.63M | -23.29M | -18.10M | -3.37M | -6.87M |
| Capital Expenditure | -363.00K | -32.00K | -40.00K | 0.00 | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 452.00K | -- | 0.00 | -44.84M | 2.50M |
| Cash from Investing | 89.00K | -32.00K | -40.00K | -44.84M | 2.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 48.00K | 100.03M | 0.00 | 328.00M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -67.00K | -6.20M | -1.17M | -24.27M | -- |
| Cash from Financing | -19.00K | 93.83M | -1.17M | 303.73M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.56M | 70.51M | -19.31M | 255.52M | -4.37M |